17-12666125-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_001146312.3(MYOCD):c.-64G>A variant causes a 5 prime UTR change. The variant allele was found at a frequency of 0.0915 in 1,263,144 control chromosomes in the GnomAD database, including 5,843 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.082 ( 568 hom., cov: 32)
Exomes 𝑓: 0.093 ( 5275 hom. )
Consequence
MYOCD
NM_001146312.3 5_prime_UTR
NM_001146312.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.21
Genes affected
MYOCD (HGNC:16067): (myocardin) This gene encodes a nuclear protein, which is expressed in heart, aorta, and in smooth muscle cell-containing tissues. It functions as a transcriptional co-activator of serum response factor (SRF) and modulates expression of cardiac and smooth muscle-specific SRF-target genes, and thus may play a crucial role in cardiogenesis and differentiation of the smooth muscle cell lineage. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.34).
BP6
Variant 17-12666125-G-A is Benign according to our data. Variant chr17-12666125-G-A is described in ClinVar as [Benign]. Clinvar id is 1222452.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0997 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYOCD | NM_001146312.3 | c.-64G>A | 5_prime_UTR_variant | 1/14 | ENST00000425538.6 | NP_001139784.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYOCD | ENST00000425538 | c.-64G>A | 5_prime_UTR_variant | 1/14 | 1 | NM_001146312.3 | ENSP00000401678.1 | |||
MYOCD | ENST00000579237.5 | n.-64G>A | non_coding_transcript_exon_variant | 1/5 | 4 | ENSP00000462694.1 | ||||
MYOCD | ENST00000579237.5 | n.-64G>A | 5_prime_UTR_variant | 1/5 | 4 | ENSP00000462694.1 |
Frequencies
GnomAD3 genomes AF: 0.0818 AC: 12449AN: 152116Hom.: 569 Cov.: 32
GnomAD3 genomes
AF:
AC:
12449
AN:
152116
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0928 AC: 103080AN: 1110910Hom.: 5275 Cov.: 15 AF XY: 0.0921 AC XY: 52344AN XY: 568480
GnomAD4 exome
AF:
AC:
103080
AN:
1110910
Hom.:
Cov.:
15
AF XY:
AC XY:
52344
AN XY:
568480
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0818 AC: 12450AN: 152234Hom.: 568 Cov.: 32 AF XY: 0.0808 AC XY: 6017AN XY: 74428
GnomAD4 genome
AF:
AC:
12450
AN:
152234
Hom.:
Cov.:
32
AF XY:
AC XY:
6017
AN XY:
74428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 20, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at